Dupilumab Targeting IL-4/IL-13 Pathway Improves RTK- and PD-1-Inhibitor-Related Cutaneous Adverse Drug Reactions.

Authors

Xiaoli Wang, Jun Ting Tang, Zhen Feng, Di Jin, Cheng Zhang, Mu Niu, Yeqiang Liu, Wuqing Wang

Published in

Scandinavian journal of immunology. Volume 104. Issue 4. Pages e70151.

PMID:
42773571
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.